Skip to main content
AKTS logo

AKTS · Aktis Oncology, Inc.

Track AKTS — free
$27.05 +0.40 (+1.50%) At close · Sep 4
Market Cap
$1.50B
Shares
55.62M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2026-07-20 KEN HERRMANN 4,856
2026-07-17 KEN HERRMANN 3,065
2026-07-08 AKOS CZIBERE 50,000
2026-07-08 SHULAMIT RON-BIGGER 50,000
Showing 1–4 of 4 filings
Key facts CIK 2035832 CUSIP 01021M104 13F (30d) 77 filings 77 filers Visit website Investor relations